Federated Hermes, Inc. Theravance Biopharma, Inc. Transaction History

Federated Hermes, Inc.

$52.5 Billion
Q3 2025

A detailed history of Federated Hermes, Inc. transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 96 shares of TBPH stock, worth $1,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$1,416

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	BUY	$10.9 - $14.6 $1,046 - $1,401	96 New	96 $1,000
Q4 2020 Feb 12, 2021	SELL	$14.89 - $20.16 $804 - $1,088	-54 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$14.79 - $22.49 $4.51 Million - $6.86 Million	-305,116 Reduced 99.98%	54 $1,000
Q2 2020 Aug 13, 2020	SELL	$20.64 - $30.69 $1.98 Million - $2.94 Million	-95,804 Reduced 23.89%	305,170 $6.41 Million
Q1 2020 May 13, 2020	BUY	$17.84 - $31.21 $7.15 Million - $12.5 Million	400,970 Added 0.0%	400,974 $9.27 Million
Q4 2019 Feb 14, 2020	SELL	$16.12 - $25.89 $290 - $466	-18 Reduced 81.82%	4 $1,000
Q3 2019 Nov 14, 2019	BUY	$16.51 - $23.78 $363 - $523	22 New	22 $1,000
Q2 2019 Aug 14, 2019	SELL	$15.6 - $25.15 $717,724 - $1.16 Million	-46,008 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$22.52 - $35.07 $1.04 Million - $1.61 Million	46,008 New	46,008 $1.18 Million

Others Institutions Holding TBPH

# of Institutions

143

Shares Held

48.7M

Call Options Held

Put Options Held

11.6K

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$140 Million
11.23% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$110 Million
1.24% of portfolio
Newtyn Management, LLC New York, NY

4.95M
Shares

$73 Million
10.56% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$55.8 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$40.7 Million
4.49% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $985M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account